Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses
Kah Lok Chan, Juliana Gomez, Chelisa Cardinez, Nishi Kumari, Christina E. Sparbier, Enid Y.N. Lam, Miriam M. Yeung, Sylvain Garciaz, James A. Kuzich, Doen Ming Ong, Fiona C. Brown, Yih-Chih Chan, Dane Vassiliadis, Elanor N. Wainwright, Ali Motazedian, Andrea Gillespie, Katie Fennell, Junyun Lai, Imran G. House, Laura MacPherson, Ching‐Seng Ang, Sarah‐Jane Dawson, Paul A. Beavis, Andrew H. Wei, Marian L. Burr, Mark A. Dawson
Topics & Concepts
Immune systemMHC class ICancerCancer researchImmunologyMHC class IIMajor histocompatibility complexBiologyMedicineInternal medicineKruppel-like factors researchCancer-related gene regulationMyeloproliferative Neoplasms: Diagnosis and Treatment